Data / Form D filings / Vivace Therapeutics, Inc.
Vivace Therapeutics, Inc.: Form D filings
Vivace Therapeutics, Inc., a biotechnology company in San Mateo, CA, filed 5 Form D notices with the SEC between 2015 and 2025. The latest, on March 12, 2025, reports $17.5 million sold of a $35 million offering to 5 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1510 Fashion Island Blvd., Suite 310, San Mateo, CA, 94404
- Phone
- (858) 344-7499
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1630575
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 12, 2025 | New notice | $34,999,993 | $17,499,997 | $17,499,996 | 5 | Feb 28, 2025 | sec.gov |
| Dec 23, 2020 | New notice | $29,999,993 | $29,999,993 | 6 | Dec 11, 2020 | sec.gov | |
| May 1, 2018 | Amendment | $24,999,998 | $8,000,008 | $16,999,990 | 6 | May 5, 2017 | sec.gov |
| May 18, 2017 | New notice | $24,999,998 | $8,000,008 | $16,999,990 | 6 | May 5, 2017 | sec.gov |
| Jan 20, 2015 | New notice | $15,050,000 | $5,050,000 | $10,000,000 | 3 | Jan 7, 2015 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Edward Hu | Director | |
| Jun Wu | Director | |
| Jake Simson | Director | |
| Tim Shannon | Director | |
| Chenguang Zhou | Director | |
| Shuang Qiao | Executive Officer, Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Mar 10, 2025 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Vivace Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.